Tagged with P

Spain Dr Antonio Alarco gives his insider take on the future of Spanish healthcare, personalized medicine, and the areas in which Spain needs to improve.   Innovation is the best investment; there will never be a real change without popular scientific divulgation With Mariano Rajoy of the People’s Party (PP) stepping…

Korea Kyoung-June Lee, CEO of JW CreaGene, lifts the lid on their novel technology of developing an immuno-oncology treatment from dendritic cells, which act as a command centre of the immune system in the body. He also assesses how this new treatment will compare to existing technologies, such as CAR-T.  …

Spain Daniel-Anibal Garcia Diego, president of the Spanish Haemophilia Federation (FEDHEMO), discusses the current situation of haemophilia treatment and healthcare coverage in Spain, as well as the unique challenges created by the autonomous regions of the country. He also gives insight into FEDHEMO’s ongoing initiatives and future objectives.   Spain is…

Korea Dr BG Rhee, CEO of SCM Lifescience discusses their patented proprietary subfraction technology to extract high purity cell cultures, and the impact this will have on the efficacy, cell differentiation ability, and cost of stem cell treatments. Dr Rhee also provides his assessment of the regulatory framework for stem cells…

Spain Alfonso Beltrán García-Echániz, director of the Spanish Foundation for Innovation and Prospective Health (FIPSE), highlights the foundation’s focus, as a new instrument to foster innovation in Spain, as well as shares his expert insights on the future of innovation in the country.   The focus of our work is to…

Spain Antonio Lopez and Diego Monux, CEO and founding partner of SILO (Science and Innovation Link Office), talk about their niche offering of connecting both the public and private sector, in addition to discussing the opportunities for companies to capitalize on the scientific offering that Spain provides.   Most of our…

Korea Professor Jong In Lim, cyber security specialist and president of the Institute for Cyber Security and Privacy (ICSP) provides his assessment of the current situation for information security in Korea, and how this applies to healthcare data.   As one of the national experts in cyber security, could you introduce…

Spain Marieta Jiménez, president and general manager of Merck Spain, highlights her three top priorities: innovation, science and technology, and women’s equality. Furthermore, she gives an overview of the need for better collaboration for long-term sustainably of the Spanish healthcare system and breaks down the role of the ClosingGap cluster to…

Spain Inês Correia, general manager of the Iberia affiliate of HRA Pharma, a fast-growing consumer healthcare company and leader in women’s health, discusses her transition to the company and challenges in the Spanish environment in the context of emergency contraception (EC). Furthermore, Correia elaborates on HRA Pharma’s strong strategy in the…

China Tony Au, general manager of AbbVie China, shares the key milestones for the affiliate in the past six years, the strong foundation he has built for AbbVie in China, the mission of AbbVie to be the most reliable pharmaceutical company in China, and the exciting pipeline of innovative products and…

Spain Eduardo Barriga, general manager of Boiron, the homeopathic market leader in Spain, discusses the company’s approach to the Spanish market since he took the position two years ago. Furthermore, Barriga explains how despite criticism, Spain is a strong market for the company and how he plans to transform the mindset…

Opinion Nawal Roy is founder and CEO of Holmusk, a company dedicated to building one of the world’s largest real-world evidence platforms for neurosciences. Here, Nawal Roy discusses the potential for real-world evidence to optimise drug life-cycle management.    Use of real-world evidence (RWE) can modernize the process of drug research, development and delivery.   The…